en

PRODUCT DETAIL

Vabysmo 120 mg/ml injekčný roztok

Code 2038E
MA number EU/1/22/1683/001
Product Form: sol inj 1x0,24 ml/28,8 mg (liek.inj.skl. + inj.ihla)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 64 - OPHTHALMOLOGICA
ATC:
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01L Ocular vascular disorder agents
S01LA Antineovascularisation agents
S01LA09 Faricimab
Shelf life: 30
Container: glass vial
Route of admin.: Intravitreal use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.09.2022
Validity: 15.09.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 20.09.2022
eu-flag.png sk-flag.png